rs373911322

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4BP6_Very_StrongBP7BS1BS2

The NM_001042432.2(CLN3):​c.240G>A​(p.Thr80Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000468 in 1,614,102 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00026 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00049 ( 7 hom. )

Consequence

CLN3
NM_001042432.2 synonymous

Scores

1
1

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -2.12

Publications

2 publications found
Variant links:
Genes affected
CLN3 (HGNC:2074): (CLN3 lysosomal/endosomal transmembrane protein, battenin) This gene encodes a protein that is involved in lysosomal function. Mutations in this, as well as other neuronal ceroid-lipofuscinosis (CLN) genes, cause neurodegenerative diseases commonly known as Batten disease or collectively known as neuronal ceroid lipofuscinoses (NCLs). Many alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2008]
CLN3 Gene-Disease associations (from GenCC):
  • inherited retinal dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • neuronal ceroid lipofuscinosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • neuronal ceroid lipofuscinosis 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Myriad Women’s Health

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.288).
BP6
Variant 16-28488645-C-T is Benign according to our data. Variant chr16-28488645-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 197712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-28488645-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 197712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-28488645-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 197712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-28488645-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 197712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-28488645-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 197712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-28488645-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 197712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-28488645-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 197712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-28488645-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 197712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-28488645-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 197712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-28488645-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 197712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-28488645-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 197712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-28488645-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 197712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-28488645-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 197712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-28488645-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 197712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-28488645-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 197712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-28488645-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 197712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-28488645-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 197712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-28488645-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 197712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-28488645-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 197712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-28488645-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 197712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-28488645-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 197712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-28488645-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 197712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-28488645-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 197712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-28488645-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 197712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-28488645-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 197712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-28488645-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 197712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-28488645-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 197712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-28488645-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 197712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-28488645-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 197712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-28488645-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 197712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.12 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000256 (39/152250) while in subpopulation SAS AF = 0.00725 (35/4830). AF 95% confidence interval is 0.00536. There are 1 homozygotes in GnomAd4. There are 30 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 7 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CLN3NM_001042432.2 linkc.240G>A p.Thr80Thr synonymous_variant Exon 5 of 16 ENST00000636147.2 NP_001035897.1 Q13286-1A0A024QZB8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CLN3ENST00000636147.2 linkc.240G>A p.Thr80Thr synonymous_variant Exon 5 of 16 1 NM_001042432.2 ENSP00000490105.1 Q13286-1

Frequencies

GnomAD3 genomes
AF:
0.000270
AC:
41
AN:
152132
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00765
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000962
AC:
242
AN:
251490
AF XY:
0.00127
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000578
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000978
GnomAD4 exome
AF:
0.000490
AC:
716
AN:
1461852
Hom.:
7
Cov.:
30
AF XY:
0.000650
AC XY:
473
AN XY:
727232
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.0000224
AC:
1
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.000277
AC:
11
AN:
39700
South Asian (SAS)
AF:
0.00772
AC:
666
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000450
AC:
5
AN:
1111986
Other (OTH)
AF:
0.000546
AC:
33
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.449
Heterozygous variant carriers
0
45
90
134
179
224
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000256
AC:
39
AN:
152250
Hom.:
1
Cov.:
32
AF XY:
0.000403
AC XY:
30
AN XY:
74454
show subpopulations
African (AFR)
AF:
0.0000481
AC:
2
AN:
41548
American (AMR)
AF:
0.00
AC:
0
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5178
South Asian (SAS)
AF:
0.00725
AC:
35
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68010
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000793
Asia WGS
AF:
0.00693
AC:
24
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 05, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
May 13, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Mar 01, 2019
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Neuronal ceroid lipofuscinosis Benign:1
Jan 14, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

CLN3-related disorder Benign:1
Jul 02, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Neuronal ceroid lipofuscinosis 3 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Pathogenic
0.14
CADD
Benign
0.43
DANN
Benign
0.96
PhyloP100
-2.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.15
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs373911322; hg19: chr16-28499966; API